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ABSTRACT: Although microRNA (miRNA) expression levels provide important
information regarding disease states owing to their unique dysregulation patterns in
tissues, translation of miRNA diagnostics into point-of-care (POC) settings has been
limited by practical challenges. Here, we developed a hydrogel-based microfluidic
platform for colorimetric profiling of miRNAs, without the use of complex external
equipment for fluidics and imaging. For sensitive and reliable measurement without the
risk of sequence bias, we employed a gold deposition-based signal amplification scheme
and dark-field imaging, and seamlessly integrated a previously developed miRNA assay
scheme into this platform. The assay demonstrated a limit of detection of 260 fM, along
with multiplexing of small panels of miRNAs in healthy and cancer samples. We anticipate
this versatile platform to facilitate a broad range of POC profiling of miRNAs in cancer-
associated dysregulation with high-confidence by exploiting the unique features of
hydrogel substrate in an on-chip format and colorimetric analysis.
Small noncoding RNAs, called microRNAs (miRNAs), havebecome increasingly important in disease diagnosis due to
their abnormal expression in many diseases such as cancer,
diabetes, neural, and heart diseases.1−4 Previous studies had
demonstrated that miRNAs have high stability and can be
detected in various biological fluids such as blood serum and
plasma.5 However, clinicians still lack proper tools for high-
confidence quantification of miRNA owing to their low
abundance and sequence homology.6,7 Most challenges arise
due to the grueling demands of an assay that could easily be
integrated into a point-of-care (POC) clinical setting.8 An ideal
platform ought to provide high sensitivity, high specificity, and
multiplexing while minimizing the use of external equipment,
and involving simple sample preparation and assay operation.
While quantitative real-time polymerase chain reaction (qRT-
PCR) is widely used as a gold standard for high sensitivity, it is
limited in practical application, due to its requirement of
substantial sample preparation steps, such as RNA extraction,
expensive instruments, and intricately complex design of
primers to avoid sequence bias arising from target-based
amplification.9,10 To address these limitations of the conven-
tional method, several techniques have now been developed
for miRNA detection, fluorescent probes,11,12 isotachopho-
resis,13,14 and nanomaterial-based in vivo sensing.15,16 Despite
advancements, the techniques do not satisfy all the require-
ments of POC regarding miRNAs, and the need for a more
clinically feasible approach still remains.17
Hydrogel-based microfluidic approach can be advantageous
in the development of reliable and affordable POC
diagnostics.18−20 The superiority of nonfouling hydrogels has
been previously demonstrated in comparison to surface-based
systems for nucleic acid hybridization, especially from
biologically complex samples.21 Better thermodynamics in
the gel increases both sensitivity and specificity, and the
solution-like environment of a hydrogel provides faster
hybridization kinetics.22 Furthermore, it is possible to directly
measure miRNAs in complex media such as cell lysate or
serum, without RNA extraction and target amplification.12,23 In
a previous gel particle-based approach, a universal labeling
scheme was developed, which allowed the use of a single label
for all captured miRNAs, and measured miRNA dysregulation
patterns.24,25 Here, we adapted the same hydrogel chemistry
and miRNA capture approach into an on-chip assay for POC
applications.
POC diagnostics can facilitate fast and accurate identi-
fication of diseases, which leads to better treatment of patients.
To fit the POC criteria of cost-effectiveness, portability, and
accessibility, miRNA assays are commonly performed with
nonfluorescent labeling molecules for visualization. Since such
assay schemes offer only low to moderate detection sensitivity,
miRNA detection methods often rely on signal boosting step,
such as enzymatic and nucleic acid amplification.26−28 The
Mirkin group has developed an assay using gold nanoparticles,
with silver or gold deposition, which had been successfully
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applied to detect various biomarkers, including miRNAs.29−31
Their method provides robust signals without bleaching issues
because of high photostability of gold-labeled conjugates, and
very short amplification step with high sensitivity while
minimizing equipment requirements.32 However, this micro-
array-based method typically requires a long assay time
(overnight hybridization of target miRNAs) with complicated
fluidic steps. Thus, we aim to integrate on-chip hydrogel assay
and gold deposition scheme to achieve sensitive POC
applications.
We leverage the advantages of microfluidic channels, and the
chemical advantages of a polyethylene glycol (PEG) hydrogel
scaffold for miRNA hybridization while optimizing an enzyme-
free gold nanoparticle-based signal amplification scheme for
POC diagnostics. Particularly, we sought to use dark-field
imaging for high sensitivity, which had previously been
demonstrated for ultrasensitive colorimetric nucleic acid
assay.33 Dark-field imaging-based methods boost the scattered
intensity of gold conjugates with white light illumination, thus
minimizing the requirement of complex and expensive
instrumentation for miRNA detection.34 With just a 15 min
signal amplification step, we achieved a limit of detection of
260 fM and multiplexed miRNA quantification with minimal
sample input. We expect this assay platform to be beneficial in
a wide range of clinical samples, including cellular lysate and
serum for POC applications.
■ EXPERIMENTAL SECTION
Microfluidic Chip Preparation. Commercial chips with
straight channels (50 μm in height, 1 mm width, and 18 mm
length) were purchased from Hilgenberg GmbH, Germany for
performing all assays. Connection ports were fabricated in
polydimethylsiloxane (PDMS) (Corning, Sylgard 184) with
holes, which were punched with 15-gauge needles. All
connection ports were bonded onto inlets and outlets of
glass chips by oxygen plasma treatment (25 s on RF = high,
Harrick Scientific, Pleasantville, NY). After a subsequent
incubation at 80 °C for 20 min, a 2% (v/v) solution of 3-
(trimethoxysilyl)propyl acrylate (Sigma) mixed in 24.5% (v/v)
1X PBS (phosphate buffered saline, Corning), and 73.5% (v/v)
ethanol was filled inside the channels for tight adhesion of the
gel pads on the glass walls. After 30 min, channels were rinsed
with ethanol and dried with argon gas. After bioassays, chips
were cleaned by soaking in 1 M NaOH for 1 h and then
washed with DI water and ethanol. Next, they were dried with
argon gas; chips were stored at 80 °C until the time of usage.
These reusable glass chips were used for several assays (more
than 10 times) by repeating the cleaning and activating
procedures.
On-Chip Hydrogel Synthesis. All chemicals were
purchased from Sigma-Aldrich (U.S.). Hydrogel posts were
synthesized using projection lithography from a polyethylene
glycol monomer mixture. The monomer mixture consisted of
20% (v/v) PEGDA 700 (poly(ethylene glycol) diacrylate, MW
= 700 g/mol), 40% (v/v) PEG 600 (poly(ethylene glycol),
MW = 600 g/mol), 5% (v/v) Darocur 1173 photoinitiator,
and 35% (v/v) 3x TE (Tris-EDTA, USB Corporation) buffer
with food coloring dye, which was previously optimized for the
diffusion and reaction in bioassays.35,36 The monomer solution
was diluted 9:1 with the acrydite-modified probes (Integrated
DNA Technologies (IDT), Coralville, IA). The concentration
of probe molecules was adjusted from the coarse rate matching
as described in a previous study (miR-21:247 μM, miR-145,
and let-7a: 50 μM).24 Probe-containing prepolymer solution
was vortexed, centrifuged, and loaded into channels by
pipetting. An inverted microscope (Zeiss Axio Observer A1)
and a CCD camera (Andor Clara) were used for UV-initiated
polymerization. With a desired photomask (Fineline Imaging)
placed in the fieldstop, the polymerization was performed at
100 ms exposure (Lumen 200, Prior Scientific) using a 20×
objective (Zeiss Plan-Neofluar) and a dichrioc filter for
excitation at 365 nm. After polymerization, channels were
rinsed with 1X TE buffer. For multiplexed assays, the
subsequent monomer solution with a different probe was
loaded in the same channel and polymerization was repeated as
described in earlier. The posts containing different probe
sequences were immobilized at spatially distinct locations in a
single channel.
Fluidic Control. All assays were performed with gravity
driven flow by appropriately inserting a 200 μL pipet tip into
PDMS inlet port. The flow rate was observed to be 1−5 μL/
min. Previously, we calculated the channel Pećlet number (Pe)
to be approximately 7000.25 With the high values of Pe (Pe≫
1), target depletion is assumed to be negligible.37 The solution
was refilled in the tip of inlet port every 10 min to maintain
height differences for a steady flow. Since our system is highly
flexible and can be incorporated with various types of flows
such as pressure-driven flows and syringe pump-driven flows,
the manual iterative operation can be avoided by simply using
an external equipment for fluidics.
MicroRNA Assay. Blocking solution of 3% (w/v) Pluronic
F108 (Sigma-Aldrich) in nuclease-free water (Affymetrix) was
filled into channels containing hydrogel posts. After 30 min,
the process of target hybridization to specific probes was
performed with the mixture of synthetic RNAs (IDT) or total
RNA (BioChain, Newark, CA) in a TET buffer with a final
concentration of 350 mM NaCl for 90 min. The sequence
information on all the probes and targets used in this study was
summarized in Supporting Information Table S1. Total RNA
was stored at 100 ng/μL at −20 °C and 500 ng of total RNA
dissolved in 200 μL was used for assay. Before performing the
assay, the solution with total RNA was incubated at 95 °C for 5
min in a thermoshaker for disrupting secondary structures, and
cooled down at room temperature. The hybridization mixture
was loaded into the microchannel through the precut pipet tips
in the injection port of the device. Target hybridization
occurred at elevated temperature (55 °C) on a hot plate, and
all subsequent steps were performed at room temperature. In
previous works, the temperature in channels was validated to
be constant based on a simple heat transfer calculation.25 For
all assays, steady flows were maintained to deliver the
molecules without depletion. In between assay steps, rinses
were performed using 50 mM NaCl in TET for 30 s to impose
sufficient stringency for high specific miRNA measurement.
For ligation, the universal linker (IDT), T4 DNA ligase (800
U/mL), ATP (250 nM), and 10× NEB2 buffer (New England
Biolabs, Ipswich, MA) were mixed in TET and incubated in
the channels for 10 min as described in previous studies.24
After washing, Nanogold-Streptavidin (80 μg/mL, Nanop-
robes, Inc., Yaphank, NY) diluted in 1× PBS (0.1% v/v) was
loaded into channels for 30 min. For gold deposition,
GoldEnhance (Nanoprobes, Inc.) was used, which consisted
of Solution A (enhancer), Solution B (activator), Solution C
(initiator), and Solution D (buffer). First, 200 μL of Solution A
and B were mixed, and after 5 min, 200 μL of Solution C and
D were added into the mixture. After vortexing, the mixture
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was delivered to the microchannels with posts for an optimal
amplification time of 15 min.
Data Acquisition and Analysis. The hydrogel posts were
imaged using a Zeiss Axio Observer A1 microscope with a 10×
objective and a dark-field condenser. Each image was analyzed
using ImageJ (National Institutes of Health).38 The color
images we obtained were split to the respective red, green, and
blue image components. The region of interest (ROI) was
identified as a post circle with a defined diameter. For each
ROI, the intensity of pixels in the red channel was only
averaged to analyze the wine-red color of miRNA-gold
conjugates. Background signal was calculated by averaging
the red pixel intensities in a region outside the post, within the
microfluidic chip. Target signal was computed by subtracting
background signal from a raw signal with target incubation
(Starget = Starget, raw − Sbackground). Control raw signal was
obtained from the posts after incubation with 0 fM of synthetic
targets. After subtracting background signal (Scontrol = Scontrol, raw
− Sbackground), the control signal serves as the assay background,
and the noise was defined as the standard deviation of the
control signals (σcontrol). Control signal was subtracted from
the desired target signal (Starget, net = Starget − Scontrol) to obtain a
net signal. This makes Scontrol, net = 0. Finally, the signal-to-noise
ratio (SNR) was determined as the ratio of net signal to assay
noise (SNR = Starget, net/σcontrol). Limit of detection of the
system was defined as the miRNA concentration at which the
SNR equals 3, as per previously published protocols.25
■ RESULTS AND DISCUSSION
Assay Development. For the development of a sensitive
miRNA assay in point-of-care (POC) diagnostics, we sought to
apply a rapid signal amplification scheme by gold deposition
onto a hydrogel-based on-chip miRNA sensor. Previously, we
had demonstrated ultrasensitive measurement of miRNAs
using oil-isolated hydrogel chambers in microfluidic chip, with
a limit of detection (LOD) of 22.6 fM.25 We had achieved high
Pećlet number in the previous work by using a gravity-driven
flow to eliminate mass transfer limits that could arise from
insufficient target molecule deliveries to the gel posts.
Importantly, this strategy eliminated the need for complicated
external flow controllers, making our system suitable for point
of care applications. However, this assay was based on
fluorescence measurements, which required expensive and
complex imaging instruments. To overcome this issue, we used
a colorimetric labeling approach based on gold deposition for
signal amplification and dark-field imaging.
As done previously, we immobilized spatially encoded
miRNA probe-bearing hydrogel posts in microfluidic channels
using projection lithography to control their size and shape
(Figure 1a). Multiplexing can be achieved with a spatial
encoding scheme by exchanging monomer solutions in the
device and polymerizing posts. The incorporated probes
consist of two domains: a miRNA-specific domain and a
universal linker domain. The linker used for labeling was the
same for all measured miRNAs. A fully controlled steady
gravity-driven flow was used for all assay steps, thus eliminating
the need for expensive and cumbersome flow controllers.
Target hybridization occurred at elevated temperatures (55
Figure 1. (A) Schematics of on-chip hydrogel post synthesis for multiplexing of small miRNA panels using projection lithography with the spatial
encoding scheme. (B) miRNA assay scheme: target hybridization, universal linker ligation, gold nanoparticle labeling, and gold ion deposition-
based signal amplification. (C) Dark-field images of posts after complete miRNA assay demonstrating the dose-dependent response of miRNAs.
Scale bar represents 100 μm.
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°C) on a hot plate, whereas all subsequent steps were
performed at room temperature (Figure 1b). We ligated the
biotinylated universal linker to the probe-target complex using
the T4 DNA ligase for 10 min. Without target miRNA bound
to the probe, the universal linker would be released during the
stringent washing step with low salt (50 mM NaCl) buffer due
to low binding affinity to probe cross-linked into the hydrogel.
Next, the probe-target complex was labeled using a
streptavidin-conjugated gold nanoparticle (SA-Au, 80 ng/mL,
30 min). Thereafter, the signal amplification scheme, based on
gold ion deposition, was applied for 15 min.
Both bright- and dark-field systems were considered for
imaging the gold-labeled target miRNAs. For system character-
ization, we used immobilized gel posts functionalized with
biotinylated DNA probe (5 nM). Although bright-field mode is
widely used in colorimetric assay, its high background signals
often generate large variations. More importantly, there was no
difference between the presence and absence of probe after
labeling streptavidin-conjugated gold nanoparticles and signal
amplification with catalytic gold deposition (Supporting
Information (SI) Figure S1). Conversely, with dark-field
illumination we observed measurable signals from 5 nM
probe. Thus, for sensitive measurement of surface plasmon
resonance (SPR) scattering from gold nanoparticles, we used
dark-field microscopy with the appearance of wine-red color.
As shown in Figure 1c, in an initial trial with miRNA assay with
the analysis using dark-field microscopy, the red dots were
gradually increased as the concentration of target miRNA
increased from 0 to 10 pM. Considering simplicity of the assay,
further analysis was performed with red channel in RGB
imaging.
Optimization and Assessment of Signal Amplifica-
tion. Since previous studies had used the gold deposition
scheme in a microarray format, we first needed to optimize the
signal amplification step in the on-chip hydrogel-based assay.
While previous studies used three rounds of 5 min gold
deposition to maximize the signal-to-noise ratio (SNR) by
increasing target-binding signal,31 we sought to run a single-
step amplification to minimize the assay complexity for POC
applications. We hypothesized that the solution-like and
nonfouling environments of hydrogel posts would be superior
to a microarray platform (rigid, planar surfaces) for gold
deposition on targets without nonspecific background. For the
optimization of the signal amplification step, we measured the
SNR as a function of gold ion deposition time. Using
immobilized gel posts functionalized with either biotinylated
DNA (final concentration of 5 nM) or no biotin (serving as
control), we loaded Nanogold-Streptavidin (80 ng/mL, PBS)
for 30 min and, after washing, GoldEnhance mixture for 5−60
min. Then, we calculated SNR, which is defined as the net
control-subtracted signal divided by the standard deviation of
control measurements (assay-derived noise). As shown in
Figure 2, SNR increased up to a time of 15 min, and then
decreased due to high background signal. This indicated that a
hydrogel-based system can achieve high sensitivity, simply with
a single-step amplification without the need of multiple rounds.
Next, we examined the assay stability, which is one of the
important considerations for reliable measurement in POC
diagnostics. An unstable signaling label would induce test
errors. Also, sometimes assay platforms might need to be
transferred from remote areas to a core facility for analysis by
experts for accurate diagnostics. With 5 nM of the biotinylated
probe, we analyzed the net signal from the gold-labeled
conjugates over 24 h, after Nanogold-Streptavidin labeling and
gold ion deposition steps. As described earlier, the net signal
was determined as control (no biotinylated probe)-subtracted
target signal. As expected, the net signal did not decrease, as
shown in SI Figure S2. Importantly, it was noted that hydrogels
and gold nanoparticles are stable for several months without
degradation,21,39 which is expected to allow long-term storage
and reimaging. Therefore, this assay platform would provide
high stability in analysis, without photobleaching, and can be
stored for a long time or be transported, if necessary, rendering
it ideal for POC diagnostics.
Detection Sensitivity. Using the gold labeling scheme, we
examined the signal changes in 10 pM spike-in of let-7a as a
function of hybridization time. The target capture increased for
90 min and then saturated, as observed in previous studies (SI
Figure S3).24,25 To minimize the RNA input requirement while
retaining high sensitivity, we decided to use 90 min of
hybridization. The 90 min hybridization was recommended
due to the stringent buffer conditions (high temperature and
low salt concentration), which we optimized earlier for specific
miRNA measurements to distinguish between even 1−2
mismatches.24,25 If necessary, we could reduce the assay
time, which would still give us a reasonable signal.
We next investigated the sensitivity of our hydrogel-based
colorimetric detection scheme for detecting miRNAs. The
synthetic miRNA spike-ins (from 100 fM to 10 pM let-7a)
were incubated in each channel of a microfluidic chip. To
account for the assay background, the net signal was
considered−the control signal (0 fmol spike-in) was subtracted
from the target signals. We show the dose-dependent
responses from let-7a spike-ins in Figure 3. As shown in SI
Figure S4, we then calculated the limit of detection (LOD),
which was previously defined in Experimental Section. Our
assay scheme provided a LOD of 260 fM, which is relatively
sensitive compared to other colorimetric assays (pM to sub-
pM).40−42 Although some recent studies on colorimetric
miRNA assays show high sensitivity (fM to sub-fM),10,43,44
their methods rely on target-based amplification with the
possible high risk of sequence bias. In addition, we might
achieve better sensitivity if we run multiple rounds of signal
amplification as a previous study optimized to perform the
three rounds of gold deposition to maximize SNR.31
Additionally, the size and geometry of hydrogel posts can be
optimized to improve the sensitivity of miRNA measurements.
In a miRNA assay with the high concentration of targets such
as 10 pM, we observed that more targets were attached to the
Figure 2. Optimization of amplification time. The signal-to-noise
ratio (SNR) was continued to increase for up to 15 min of gold
deposition-based signal amplification. After achieving a maximum
value at 15 min, SNR decreased and then saturated due to nonspecific
binding of gold ions. Error bars represent standard deviation (n = 8−
15).
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edge of the post, rather than evenly distributed (Figure 1c).
Previously, we optimized the pore size of gel scaffold to allow
the fast diffusion of molecules. However, the rapid deposition
of gold ions seems to affect the transport rate of labeling
molecules, especially with the high level of probe-target
conjugates. To consider flux into porous hydrogel posts, we
could use ring structures instead of disk shapes as in a recent
publication.20 By analyzing a ring-area around the edges, we
expect that we could achieve higher mean signal and better
sensitivity, which would be beneficial in POC diagnostics.
Multiplex Detection. After characterization, we measured
the cross-reactivity of three microRNAs. Three clinical miRNA
targets relevant in lung tumor were considered in this study:
let-7a, miR-145, and miR-21. We immobilized three types of
hydrogel posts, bearing each miRNA probe using the spatial
encoding scheme. As shown in SI Figure S5, there was no
significant interference among three different miRNA targets
(∼20% of cross-reactivity). This minimal cross-reactivity of our
hydrogel-based miRNA assay scheme enabled multiplexing
analysis of small panels of miRNAs.
For multiplexing, each miRNA probe concentration was
adjusted by coarse-rate matching (Experimental Section). All
three miRNAs were expected to follow the same rate under the
same hybridization condition (salt and temperature). To verify
this hypothesis for the hydrogel-based colorimetric assay, we
measured the detection limit for each microRNA target based
on the calibration curve (SI Figure S4). As expected, all three
microRNA targets showed similar LOD (SI Table S2).
As a proof of concept, we compared the miRNA expression
in tumor and healthy tissue from total RNA samples using the
colorimetric platform developed here. With the posts bearing
three miRNA probes (let-7a, miR-145, and miR-21), we
performed the multiplexed assay with total RNA samples, and
we observed the dysregulation patterns of the three miRNA
targets in healthy and tumor tissue (Figure 4). The patterns are
consistent with prior studies the literature, since the expression
of both let-7a and mir-145 are known to be decreased in lung
tumor tissue, whereas that of miR-21 is elevated.24,25,45,46 Also,
by using the same total RNA sample, signal from this
colorimetric assay were comparable to those in previous
studies25 using fluorescent labels (phycoerythrin-conjugated
streptavidin reporter, SA-PE) (SI Figure S6), which were
previously validated with qRT-PCR.24 This consistency with
prior work demonstrates the high performance and reprodu-
cibility of our new miRNA measurement without using
expensive fluorescence detection.
■ CONCLUSIONS
Here, we present a technique for miRNA quantification in
point-of-care (POC) diagnostics by using gold deposition-
based signal amplification scheme with the on-chip hydrogel
sensor platform. Unlike previous studies, the colorimetric assay
developed here demonstrated highly stable and reliable
miRNA measurement without the need of expensive instru-
ments. This assay provided a limit of detection of 260 fM,
which is relatively sensitive compared to other colorimetric
assays. Moreover, our system enabled multiplex analysis of
small panels of miRNAs with relatively simple assay steps. We
successfully analyzed the dysregulation of miRNAs in lung
tumor with respect to that in healthy tissues. In the future, it
might be possible to integrate smartphone-based imaging
system for immediate processing and analysis, with the help of
smart algorithms. We envision that our system to have wide-
ranging applications in POC clinical settings for various targets
such as miRNAs, RNAs, DNA, and proteins.
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